Positive Surgical Margins in Sinonasal Cancer: A Contemporary Analysis of Risk Factors and Survival
Abstract
ABSTRACT Background Sinonasal cancers (SNCs) are rare, aggressive malignancies in which surgery remains a cornerstone of multimodal treatment. Contemporary national data on positive surgical margins (PSM), risk factors, and survival implications are limited. We evaluated temporal trends, predictors, and prognostic significance of PSMs in SNC. Methods We performed a retrospective cohort study using the National Cancer Database (2015–2022). Adults with cT1–4bN0M0 SNC undergoing definitive surgery were included; those with unknown tumor size, prior malignancy, or missing margin status were excluded. PSM trends were assessed using the Cuzick test and logistic regression; risk factors using generalized linear models; and overall survival using Kaplan–Meier, multivariable Cox proportional hazards, and 1:1 propensity score‐matched analyses. Results The final cohort included 753 patients (mean age 63.4 years [SD 11.8]; 33.2% female). PSMs occurred in 253 patients (33.6%), increasing from 29.6% in 2015 to 41.8% in 2022 (adjusted OR 1.09/year, 95% CI 1.02–1.17). Independent predictors included cT3–T4b stage (aRR 1.53, 95% CI 1.09–2.13), maxillary sinus origin (aRR 1.54, 95% CI 1.22–1.96), Charlson–Deyo score ≥ 3 (aRR 1.42, 95% CI 1.01–1.99), conversion to open surgery (aRR 2.01, 95% CI 1.14–3.55), and Native American race (aRR 2.92, 95% CI 1.65–5.18). PSMs independently predicted worse survival in multivariable (HR 1.67, 95% CI 1.27–2.19) and propensity score‐matched analyses (aHR 2.13, 95% CI 1.39–3.26). Conclusions PSMs remain common in SNC, increasing over time and independently predicting worse survival. Efforts to refine surgical techniques and multidisciplinary, histology‐guided treatment strategies may improve oncologic outcomes. Level of Evidence 3.